Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Two Firms Prep Pivotal Trials For Devices To Prevent Kidney Injury In The Cath Lab

This article was originally published in The Gray Sheet

Executive Summary

Contrast agents are fundamental tools for diagnostic and interventional cath lab procedures, but they come with the risk of acute kidney damage.
Advertisement

Related Content

News Briefs: Dx Bill Reintroduced; FDA Questions Guided Therapeutics’ LuViva; Study Milestones
Live Transmission Of TAVR Found Safe, And More From Annual SCAI Conference
Financings In Brief
ACC Meeting In Brief
ACC Meeting In Brief

Topics

Advertisement
UsernamePublicRestriction

Register

MT030512

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel